Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $2 Million - $3.93 Million
31,400 Added 24.25%
160,900 $10.8 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $8.23 Million - $13.5 Million
81,300 Added 168.67%
129,500 $15.4 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $230,499 - $311,688
-2,700 Reduced 5.3%
48,200 $5.14 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $3.01 Million - $4.52 Million
43,300 Added 569.74%
50,900 $5.06 Million
Q3 2023

Nov 15, 2023

BUY
$96.41 - $126.61 $732,716 - $962,236
7,600 New
7,600 $785,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.